Owen B. Wallace
Chief Scientific Officer, Fulcrum Therapeutics (United States).
Companies
- Monte Rosa TherapeuticsChief Scientific Officer Jun 23, 2021 to Jan 4, 20241
- Fulcrum Therapeutics (United States)Chief Scientific Officer Jul 17, 2019 to Sep 14, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Monte Rosa Therapeutics GLUE5,266 shares3$53.3K at $10.12Jan 4, 2024
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3